In this setting, donor NK cells mature under the influence of the MHC of the donor’s hematopoietic system which directs the licensing of all NK cells that bear inhibitory receptors for self-MHC resulting in NK cell alloreactivity toward tumor cells of patients that lack the appropriate MHC alleles [11–13]. This evidence concerns the gene HLA-C and neoplasm.